No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
PCVX Vaxcyte
- 76.060
- -0.880-1.14%
Close Jul 2 16:00 ET
- 76.060
- 0.0000.00%
Post 16:56 ET
8.27BMarket Cap-17729P/E (TTM)
77.160High75.270Low508.40KVolume76.800Open76.940Pre Close38.66MTurnover0.51%Turnover RatioLossP/E (Static)108.80MShares82.04052wk High4.17P/B7.55BFloat Cap44.20052wk Low--Dividend TTM99.30MShs Float82.040Historical High--Div YieldTTM2.46%Amplitude15.510Historical Low76.037Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Insider Sale: COO Jim Wassil Sells 3,000 Shares of Vaxcyte Inc (PCVX)
Vaxcyte(PCVX.US) Officer Sells US$127.3K in Common Stock
$Vaxcyte(PCVX.US)$ Officer Eydelman Mikhail sold 1,667 shares of common stock on Jul 1, 2024 at an average price of $76.3671 for a total value of $127.3K.Source: Announcement What is statement of chan
Vaxcyte(PCVX.US) Officer Sells US$229.01K in Common Stock
$Vaxcyte(PCVX.US)$ Officer Wassil Jim sold 3,000 shares of common stock on Jul 1, 2024 at an average price of $76.3376 for a total value of $229.01K.Source: Announcement What is statement of changes i
Vaxcyte(PCVX.US) Officer Sells US$199.69K in Common Stock
$Vaxcyte(PCVX.US)$ Officer PICKERING GRANT sold 2,616 shares of common stock on Jul 1, 2024 at an average price of $76.334 for a total value of $199.69K.Source: Announcement What is statement of chang
Vaxcyte Appoints John Furey as New Independent Board Director
Express News | Vaxcyte Appoints John Furey to Board of Directors
Comments
» Holdings: 112
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings(CERE.US$
$Amicus Therapeutics(FOLD.US$
$Iovance Biotherapeutics(IOVA.US$
$Arcellx(ACLX.US$
$Nuvalent(NUVL.US$
$Apogee Therapeutics(APGE.US$
$Inhibrx(INBX.US$
$Fusion Pharmaceuticals(FUSN.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Vaxcyte(PCVX.US$
$Soleno Therapeutics(SLNO.US$
$Medtronic(MDT.US$
$Madrigal Pharmaceuticals(MDGL.US$
...
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings(CERE.US$
$Amicus Therapeutics(FOLD.US$
$Iovance Biotherapeutics(IOVA.US$
$Arcellx(ACLX.US$
$Nuvalent(NUVL.US$
$Apogee Therapeutics(APGE.US$
$Inhibrx(INBX.US$
$Fusion Pharmaceuticals(FUSN.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Vaxcyte(PCVX.US$
$Soleno Therapeutics(SLNO.US$
$Medtronic(MDT.US$
$Madrigal Pharmaceuticals(MDGL.US$
...
8
» Holdings: 75
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US$
$Vaxcyte(PCVX.US$
$Legend Biotech(LEGN.US$
$Janux Therapeutics(JANX.US$
$Aerovate(AVTE.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Evolent Health(EVH.US$
$NewAmsterdam Pharma(NAMS.US$
$RxSight(RXST.US$
$TYRA BIOSCIENCES, INC.(TYRA.US$
$Edgewise Therapeutics(EWTX.US$
$4D Molecular Therapeutics(FDMT.US$
$Biogen(BIIB.US$
$PepGen(PEPG.US$
...
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US$
$Vaxcyte(PCVX.US$
$Legend Biotech(LEGN.US$
$Janux Therapeutics(JANX.US$
$Aerovate(AVTE.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Evolent Health(EVH.US$
$NewAmsterdam Pharma(NAMS.US$
$RxSight(RXST.US$
$TYRA BIOSCIENCES, INC.(TYRA.US$
$Edgewise Therapeutics(EWTX.US$
$4D Molecular Therapeutics(FDMT.US$
$Biogen(BIIB.US$
$PepGen(PEPG.US$
...
7
$Vaxcyte(PCVX.US$ sold it here can back anytime
$Vaxcyte(PCVX.US$ looks less promising day tomorrow selling at open not a good company for now
1
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg